Survey

How are the Trump tariffs affecting you? Take our survey and let us know.

OTC Markets EXMKT - Delayed Quote USD

Marizyme, Inc. (MRZM)

0.0003

0.0000

(0.00%)

At close: April 23 at 4:00:00 PM EDT

Qualigen seeks to enter the $10 Billion CABG market with non-binding MOU to acquire Marizyme

CARLSBAD, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today they have entered a non-binding Memorandum of Understanding (MOU) to acquire Marizyme (OTC: MRZM). Qualigen and Marizyme have entered an MOU dated March 28, 2025. This is the logical next step in acquiring Marizyme, following on our co-marketing agreement established in 2024. Upon completion of full due diligence, we will proceed with the final structure and deal terms

GlobeNewswire 23 days ago

QLGN

MRZM
0.00%
Marizyme, Inc. Secures FDA 510(k) Clearance for Controlled Room Temperature Storage DuraGraft

JUPITER, FL - (NewMediaWire) - May 06, 2024 - Marizyme, Inc. (OTCQB: MRZM) is pleased to announce that its flagship product DuraGraft(R) will no longer require refrigerated storage and will be able to be stored at controlled room temperatures of 20oC...

NewMediaWire 11 months ago

MRZM
0.00%

Performance Overview

Return	MRZM	S&P 500 (^GSPC)
YTD	-96.34%	-6.75%
1-Year	-99.68%	+8.15%
3-Year	-99.98%	+28.40%